Dr. Prakash Varadarajan, MD

  • Seattle, WA
  • Hematologist and oncologist
NPI1134364516PAC ID9537325089
Medicare services, 2024
1,458
Medicare patients, 2024
233
Part D claims, 2024
1,577
Publications
3
Clinical trials
1
Practice address
825 Eastlake Avenue East, Seattle, WA 98109
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Fred Hutchinson Cancer Center

Hospital · Seattle, Washington

See all 5 affiliations

Find Dr. Varadarajan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Prakash Varadarajan is a hematologist and oncologist in Seattle, Washington

Dr. Varadarajan practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Dr. Varadarajan's NPI, 1134364516, was assigned on December 12, 2008. Dr. Varadarajan holds Washington license MD60614514.

NPI and contact details
Medicare PAC ID
9537325089
NPI enumeration date
December 12, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
49
Medical school graduation
2003

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Prakash Varadarajan practices at Fred Hutchinson Cancer Center in Seattle, Washington

Dr. Varadarajan's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Source: Dmand AI Affiliation Data

Dr. Prakash Varadarajan is affiliated with 4 sites of care and 1 medical group

Dr. Varadarajan's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dr. Varadarajan is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Varadarajan to 2 more hospitals, each named with a free account.

See all 5 affiliations for Dr. Varadarajan

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Prakash Varadarajan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Varadarajan practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Fred Hutchinson Cancer CenterAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Varadarajan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Fred Hutchinson Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Prakash Varadarajan is one of 348 hematologists and oncologists in Washington

Hematology and oncology is Dr. Varadarajan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Varadarajan is licensed in Washington.

Specialties and state licenses

  • Hematology and oncology, WashingtonPrimaryLicense MD60614514 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Varadarajan

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Prakash Varadarajan billed Medicare for 1,458 services in 2024

CMS data shows 1,458 Medicare services from Dr. Varadarajan across 11 procedure codes in 2024, for 233 Medicare patients. Medicare paid $95,067 for them.

Medicare services, 20241,458
Medicare patients233
Paid by Medicare$95,067
Procedure codes11

Dr. Varadarajan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 8372024: 837No change
Other services
2023: 312024: 6211903%

Where Dr. Varadarajan's Medicare services took place, 2024

  • In an office1,36594%
  • In a facility936%

Dr. Varadarajan compared with the Washington median for hematologists and oncologists, 2024

  • Dr. Varadarajan
  • Washington median
Medicare services
1,458vs 5852.5 times
Medicare patients
233vs 18228% above
Part D claims
1,214vs 2834.3 times

Medians across 310 hematologists and oncologists in Washington with Dmand AI profiles that report each measure.

Dr. Varadarajan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Varadarajan

Need commercial claims for Dr. Varadarajan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Varadarajan and other hematologists and oncologists in Washington.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Prakash Varadarajan treated 233 Medicare patients in 2024, average age 75

CMS counts 233 Medicare patients who saw Dr. Varadarajan in 2024. The largest group is 65 to 74, with 103 patients. 70% of them have high blood pressure, and 65% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Varadarajan's median patient age at 70, with 41% women.

Medicare patients, 2024233
Average age75
Average risk score1.99
Also on Medicaid6%

Dr. Varadarajan's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Varadarajan's Medicare patients by sex, 2024

  • Women9340%
  • Men14060%

Chronic conditions among Dr. Varadarajan's Medicare patients, 2024

  1. High blood pressure70%
  2. High cholesterol65%
  3. Cancer44%
  4. Arthritis39%
  5. Ischemic heart disease32%
  6. Chronic kidney disease27%
  7. Diabetes25%
  8. Atrial fibrillation24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Varadarajan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women41%
  • Men58%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Prakash Varadarajan wrote 1,577 Medicare Part D claims in 2024

In 2024, Dr. Varadarajan wrote 1,577 Medicare Part D claims for 195 patients. 78% of them were for generic drugs. CMS names the drug for 1,214 of them, across 41 drugs with 11 or more claims each, at $4,229,130 in total drug cost. In 2023, CMS named 1,187 claims across 39 drugs.

Part D claims, 20241,577
Drugs named by CMS41
Total drug cost$4.2M
Part D patients195

Dr. Varadarajan's Part D claims by kind of drug, 2024

  • Generic1,227 claims78%
  • Brand-name and other350 claims22%

Dr. Varadarajan's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Varadarajan's Part D claims, 2024

  • Opioids4%66 of 1,577 claims
  • Antibiotics2%26 of 1,577 claims
  • Antipsychotics, patients 65 and over1%21 of 1,577 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,1872024: 1,2142%

Drugs named by CMS: 41 in 2024, 39 in 2023.

See all prescribing by Dr. Varadarajan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Prakash Varadarajan scored 94 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Varadarajan for performance year 2024, reported through an alternative payment model (APM). Dr. Varadarajan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Varadarajan as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Varadarajan's MIPS scores, performance year 2024

  • 94of 100Final score
  • 74.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Varadarajan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Prakash Varadarajan has 3 publications on record

Dmand AI links 3 papers to Dr. Varadarajan, published from 2011 to 2016. Dr. Varadarajan's most frequent co-authors are Athanassios Argiris, MD, Ralph J. Deberardinis, MD, PhD and Yissela Analy Escobedo.

Papers3
Years published2011 to 2016

Dr. Varadarajan's papers by year, 2011 to 2016

Dr. Varadarajan's most frequent co-authors

Recent publications by Dr. Varadarajan

See all 3 publications and co-authors

See who Dr. Varadarajan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Varadarajan works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Prakash Varadarajan has worked on 1 clinical trial

Dmand AI links Dr. Varadarajan to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

Conditions in Dr. Varadarajan's trials

  • Prostatic Neoplasms
  • Prostatic Diseases

Investigators on the most trials with Dr. Varadarajan

Recent clinical trials with Dr. Varadarajan

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Prakash Varadarajan received $2,039 in industry payments from 2016 to 2021

CMS Open Payments shows 132 general payments to Dr. Varadarajan from 26 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $442.

General payments to Dr. Varadarajan by program year, 2016 to 2021

General payments to Dr. Varadarajan by kind, 2016 to 2021

$2Kin total
  • Food and beverage$2,00898%
  • Education$312%

Companies that paid Dr. Varadarajan the most, 2016 to 2021

Share is of all general payments to this clinician.

See all payments to Dr. Varadarajan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Prakash Varadarajan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Prakash Varadarajan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Prakash Varadarajan's NPI number?

Dr. Prakash Varadarajan's NPI number is 1134364516. It was assigned on December 12, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Prakash Varadarajan?

Dr. Prakash Varadarajan is a hematologist and oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Prakash Varadarajan practice?

Dr. Varadarajan practices at 825 Eastlake Avenue East, Seattle, WA 98109. Dr. Varadarajan's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dmand AI also links Dr. Varadarajan to 2 hospitals.

What is Dr. Prakash Varadarajan's medical license number?

Dr. Varadarajan holds Washington license MD60614514.

Which hospitals is Dr. Prakash Varadarajan affiliated with?

Dr. Varadarajan practices at Fred Hutchinson Cancer Center in Seattle, Washington. Dr. Varadarajan is also affiliated with UW Medical Center - Montlake. Dmand AI links Dr. Varadarajan to 2 more hospitals.

What medical group is Dr. Prakash Varadarajan part of?

Dr. Varadarajan is linked to UW Physicians.

Does Dr. Prakash Varadarajan accept Medicare?

Yes. CMS data shows Dr. Varadarajan billed Medicare for 1,458 services in 2024, and Dr. Varadarajan accepts Medicare assignment.

Does Dr. Prakash Varadarajan offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Varadarajan as offering telehealth services.

What is Dr. Prakash Varadarajan's MIPS score?

Dr. Varadarajan's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Prakash Varadarajan see?

CMS counts 233 Medicare patients who saw Dr. Varadarajan in 2024, with an average age of 75.

Show 6 more questionsShow fewer questions

What services does Dr. Prakash Varadarajan bill to Medicare?

In 2024, Dr. Varadarajan's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and office visit, established patient (99214).

What drugs does Dr. Prakash Varadarajan prescribe most?

In 2024 Medicare Part D data, Dr. Varadarajan's most prescribed drugs by claims were Prednisone, Abiraterone Acetate and Ondansetron HCl.

Has Dr. Prakash Varadarajan received payments from drug or device companies?

CMS Open Payments shows $2,039 in general payments to Dr. Varadarajan from 26 companies from 2016 to 2021. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Prakash Varadarajan been practicing?

Dr. Varadarajan graduated from medical school in 2003, 23 years ago.

Does Dr. Prakash Varadarajan do research?

Dmand AI links 3 publications to Dr. Varadarajan, published from 2011 to 2016. Dr. Varadarajan has worked on 1 clinical trial.

Who does Dr. Prakash Varadarajan publish with?

Dr. Varadarajan's most frequent co-authors are Athanassios Argiris, MD (1 shared paper), Ralph J. Deberardinis, MD, PhD (1 shared paper) and Yissela Analy Escobedo (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Washington by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)